J&J Janssen unit, SRI International to collaborate on drug discovery using AI
For this year the company from New Brunswick could earn a total revenue around 94.28 billion USD. This is according to the average of the analysts' estimates. This is quite more than 2021's revenue of 82.58 billion USD.
Historical revenues and results Johnson & Johnson plus estimates 2021
The analysts expect for 2021 a net profit of 26.14 billion USD. The majority of the analysts expects for this year a profit per share of 9.8 USD. The price/earnings-ratio is then 17.22.
Per share the analysts are expecting a dividend of 4.16 USD per share. Thus the dividend yield equals 2.47 percent. The average dividend yield of the health care companies equals a moderate 1.27 percent.
Newest target prices around 177 USD
Credit Suisse , KBC Securities and Citigroup recently provided recommendations for the stock.Johnson & Johnson 's market capitalization is around 444.26 billion USD. 8
On Thursday, the stock closed at 168.76 USD.Historical stock prices Johnson & Johnson
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
